Cyclacel Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €36.68K -89.8% -€9.56M -50.3% -26,074.4% -210 pp -€6.82M -50.4% -18,581.4% -150 pp
    €358.24K +∞% -€19.24M +6.4% -5,370.2% -54 pp -€13.74M -22.6% -3,834.8% -38 pp
    €0.00 +NaN% -€18.08M +12.2% N/A -€17.76M +12.5% N/A
    €0.00 +NaN% -€16.11M +123.6% N/A -€15.79M +136.2% N/A
    €0.00 +NaN% -€7.20M +7.9% N/A -€6.69M -16.9% N/A
    €0.00 -100.0% -€6.68M +7.4% N/A -€8.05M +41.7% N/A
    €127.94K +∞% -€6.22M -2.4% -4,858.7% -49 pp -€5.68M -10.8% -4,441.3% -44 pp
    €0.00 -100.0% -€6.37M -36.6% N/A -€6.37M -25.9% N/A
    €719.04K -56.6% -€10.06M -17.8% -1,398.7% -6.6 pp -€8.59M -30.2% -1,195.3% -4.5 pp
    €1.66M +12.1% -€12.23M -26.0% -737.8% +3.8 pp -€12.30M -21.6% -742.1% +3.2 pp
    €1.48M +60.0% -€16.54M +90.9% -1,118.1% -1.8 pp -€15.69M +2.2% -1,060.7% +6.0 pp
    €924.60K +1,471.0% -€8.66M -23.0% -936.6% +180 pp -€15.35M +49.5% -1,659.7% +160 pp
    €58.85K -90.1% -€11.25M -13.5% -19,110.1% -170 pp -€10.26M -13.9% -17,436.2% -150 pp
    €596.21K +1.9% -€13.00M -4.9% -2,180.7% +1.5 pp -€11.92M -12.9% -1,998.7% +3.4 pp
    €585.12K -24.7% -€13.67M -18.1% -2,335.4% -1.9 pp -€13.68M +5.7% -2,337.6% -6.7 pp
    €777.04K +3.9% -€16.69M -51.5% -2,148.2% +25 pp -€12.95M -48.6% -1,666.1% +17 pp
    €748.04K +579.8% -€34.45M +67.9% -4,605.0% +140 pp -€25.20M +38.2% -3,368.2% +130 pp
    €110.03K -66.7% -€20.52M -17.8% -18,645.7% -110 pp -€18.23M +9.5% -16,563.6% -120 pp
    €330.09K +8.7% -€24.96M +62.1% -7,560.2% -25 pp -€16.64M -5.4% -5,040.1% +7.5 pp
    €303.65K -61.5% -€15.39M -54.4% -5,069.7% -7.9 pp -€17.58M +23.9% -5,789.3% -40 pp
    €788.98K +444.1% -€33.77M +114.5% -4,279.8% +66 pp -€14.19M +14.8% -1,798.8% +67 pp
    €145.00K -€15.74M -10,857.1% -€12.36M -8,524.1%

    Notifications